Nacsys (Acetylcysteine)

Acetylcysteine, the active ingredient in Nacsys, is a mucolytic presented as an oral formulation for oral use. It helps reduce the viscosity of respiratory mucus and is used in adults with chronic bronchitis, chronic obstructive pulmonary disease, bronchiectasis, and acute respiratory infections.

GNH USA supplies Nacsys as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global logistics for regulated medicinal products. Customers benefit from consistent batch release, traceability, and responsive technical support.

Acetylcysteine is used as a mucolytic agent to improve mucus clearance in several respiratory conditions.

- Chronic bronchitis: reduces mucus thickness, facilitating expectoration and improving airflow. - Chronic obstructive pulmonary disease (COPD): helps clear airway secretions, easing breathing difficulties. - Bronchiectasis: loosens thick sputum, supporting airway hygiene and reducing infection risk. - Acute respiratory infections: accelerates mucus clearance, aiding symptom relief and recovery.

Acetylcysteine is generally well tolerated, but several adverse reactions have been reported.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Vomiting: occasional emesis after oral intake. - Diarrhea: loose stools, usually transient. - Taste disturbance: a sulfur-like or unpleasant taste. - Abdominal discomfort: mild cramps or pain.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with rash, swelling, and breathing difficulty. - Stevens‑Johnson syndrome: rare severe skin eruption. - Bronchospasm: sudden narrowing of airways, especially in asthmatic patients. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Neutropenia: marked reduction in white blood cells.

When using Nacsys, certain precautions should be observed to ensure safe and effective therapy. - Pregnancy: safety not established; use only if potential benefit justifies potential risk. - Breastfeeding: unknown excretion; consider risk versus benefit before use. - Renal impairment: may require dose adjustment; monitor renal function. - Asthma: can provoke bronchospasm; administer with caution in reactive airway disease. - Drug interactions: review concomitant medications for potential interactions. - Store at room temperature: keep in original packaging, protect from moisture and light.

Acetylcysteine can affect the pharmacokinetics or pharmacodynamics of several medicines.

Major Interactions (Avoid): - Nitroglycerin: concurrent use may cause marked hypotension. - Chemotherapy agents (e.g., cyclophosphamide): increased toxicity risk. - Anticoagulants (e.g., warfarin): may enhance anticoagulant effect and bleeding.

Moderate Interactions (Monitor Closely): - Carbapenem antibiotics (e.g., imipenem): may reduce acetylcysteine efficacy. - Bronchodilators (e.g., albuterol): additive respiratory effects possible. - Alcohol: may increase gastrointestinal irritation.